VICINIUM Trademark

Trademark Overview

On Thursday, October 30, 2014, a trademark application was filed for VICINIUM with the United States Patent and Trademark Office. The USPTO has given the VICINIUM trademark a serial number of 86440173. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 22, 2022. This trademark is owned by Viventia Bio Inc.. The VICINIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs
vicinium

General Information

Serial Number86440173
Word MarkVICINIUM
Filing DateThursday, October 30, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 22, 2022
Registration Number4886780
Registration DateTuesday, January 12, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2015

Trademark Statements

Goods and ServicesPharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 22, 2022
Primary Code005
First Use Anywhere DateFriday, July 31, 2015
First Use In Commerce DateFriday, July 31, 2015

Trademark Owner History

Party NameSESEN BIO, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameViventia Bio Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWinnipeg, Ontario
CA
Party NameViventia Bio Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWinnipeg, Ontario
CA
Party NameViventia Bio Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWinnipeg, Ontario
CA

Trademark Events

Event DateEvent Description
Friday, July 22, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, January 12, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 25, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, July 22, 2020WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, July 22, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, January 12, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, December 8, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, December 5, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 23, 2015STATEMENT OF USE PROCESSING COMPLETE
Monday, November 2, 2015USE AMENDMENT FILED
Monday, November 9, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 2, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, October 22, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2015SOU EXTENSION 1 GRANTED
Tuesday, October 20, 2015SOU EXTENSION 1 FILED
Tuesday, October 20, 2015TEAS EXTENSION RECEIVED
Tuesday, October 6, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 6, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 21, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 5, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 29, 2014ASSIGNED TO EXAMINER
Friday, November 14, 2014PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, November 14, 2014ASSIGNED TO LIE
Wednesday, November 12, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 10, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, November 3, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

vicinium anti cancer drugs therapeutic namely biotechnology products pharmaceutical